These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 9635566

  • 1. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
    Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S.
    Cancer Res; 1998 Jun 15; 58(12):2489-99. PubMed ID: 9635566
    [Abstract] [Full Text] [Related]

  • 2. Biologic activities of natural and synthetic type I interferons.
    Pfeffer LM.
    Semin Oncol; 1997 Jun 15; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
    [Abstract] [Full Text] [Related]

  • 3. New developments in interferon therapy.
    Tossing G.
    Eur J Med Res; 2001 Feb 28; 6(2):47-65. PubMed ID: 11313191
    [Abstract] [Full Text] [Related]

  • 4. Biological basis for a proper clinical application of alpha interferons.
    Antonelli G.
    New Microbiol; 2008 Jul 28; 31(3):305-18. PubMed ID: 18843884
    [Abstract] [Full Text] [Related]

  • 5. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
    Walter MR, Bordens R, Nagabhushan TL, Williams BR, Herberman RB, Dinarello CA, Borden EC, Trotta PP, Pestka S, Pfeffer LM.
    Cancer Biother Radiopharm; 1998 Jun 28; 13(3):143-54. PubMed ID: 10850350
    [Abstract] [Full Text] [Related]

  • 6. Second-generation interferons for cancer: clinical targets.
    Borden EC, Lindner D, Dreicer R, Hussein M, Peereboom D.
    Semin Cancer Biol; 2000 Apr 28; 10(2):125-44. PubMed ID: 10936063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Alpha interferons--new therapeutic modalities].
    Bajcetić M, Zigon N, Samardzić R, Beleslin DB.
    Med Pregl; 1998 Apr 28; 51(3-4):135-9. PubMed ID: 9611956
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN.
    Hu R, Bekisz J, Hayes M, Audet S, Beeler J, Petricoin E, Zoon K.
    J Immunol; 1999 Jul 15; 163(2):854-60. PubMed ID: 10395679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The human interferon alpha species and receptors.
    Pestka S.
    Biopolymers; 2000 Jul 15; 55(4):254-87. PubMed ID: 11169919
    [Abstract] [Full Text] [Related]

  • 14. Interference by interferons: Janus faces in vascular proliferative diseases.
    Wessely R.
    Cardiovasc Res; 2005 Jun 01; 66(3):433-43. PubMed ID: 15914108
    [Abstract] [Full Text] [Related]

  • 15. Type I interferons: ancient peptides with still under-discovered anti-cancer properties.
    Caraglia M, Dicitore A, Marra M, Castiglioni S, Persani L, Sperlongano P, Tagliaferri P, Abbruzzese A, Vitale G.
    Protein Pept Lett; 2013 Apr 01; 20(4):412-23. PubMed ID: 23016588
    [Abstract] [Full Text] [Related]

  • 16. Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions.
    Pfeffer LM, Wang C, Constantinescu SN, Croze E, Blatt LM, Albino AP, Nanus DM.
    J Urol; 1996 Nov 01; 156(5):1867-71. PubMed ID: 8863634
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases.
    Dec M, Puchalski A.
    Pol J Vet Sci; 2008 Nov 01; 11(2):175-86. PubMed ID: 18683548
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.